BridgeMD
New treatment option for Systolic Left Ventricular Dysfunction
Official title The C-MIC-II Follow-Up Study
ClinicalTrials.gov ID: NCT05189860
What this study is testing
- What it's testing
- The C-MIC System is a medical device used to treat heart failure per the intended purpose which is to treat heart failure by applying an electrical micro-current to the heart. Target patients for this study are patients who have received the device in a prior study.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 75
You may be able to join if
- Patients who have received a C-MIC System during the C-MIC-II Study.
- Informed consent in writing from the patient.
You likely can't join if
- Patients who are unwilling or unable to participate in the study visits.
- Vulnerable Patients.
The study team makes the final eligibility decision.
Where it's taking place
- Banja Luka, Banja Luka, Bosnia and Herzegovina
- Sarajevo, Sarajevo, Bosnia and Herzegovina
- Zagreb, City of Zagreb, Croatia
- Skopje, North Macedonia
- Belgrade, Serbia
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 75 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Banja Luka, Banja Luka, Bosnia and Herzegovina; Sarajevo, Sarajevo, Bosnia and Herzegovina; Zagreb, City of Zagreb, Croatia; Skopje, North Macedonia; Belgrade, Serbia. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.